These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6123834)

  • 21. Relationship between structure and drug-induced parkinsonism.
    Sawada Y; Nasu R; Matsuo H; Ohtani H
    Ann Pharmacother; 2000 May; 34(5):668. PubMed ID: 10852100
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE; Povlsen UJ; Meidahl B; Gerlach J
    Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuroleptic parkinsonism].
    Izakson KhA
    Med Sestra; 1986 Sep; 45(9):50-2. PubMed ID: 2880275
    [No Abstract]   [Full Text] [Related]  

  • 25. [Report on an open investigation on bromperidol, a neuroleptic of the butyrophenone series].
    Fleischhauer J
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():30-7. PubMed ID: 35476
    [No Abstract]   [Full Text] [Related]  

  • 26. [Psychopharmaceutic agents].
    van der Kuy A; van den Bemd AA; Beysens AJ
    Tijdschr Ziekenverpl; 1976 May; 29(11):523-5 contd. PubMed ID: 13515
    [No Abstract]   [Full Text] [Related]  

  • 27. Retropulsion and back bruises in drug-induced parkinsonism.
    Karanec K; McWilliams-Dunnigan L; Alshekhlee A
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):123.E23. PubMed ID: 20160233
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
    Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
    Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced parkinsonism].
    Levin OS; Shindriaeva NN; Anikina MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):76-81. PubMed ID: 23096050
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
    Sadananda SK; Holla B; Viswanath B; Narasimha A; Sebastian A; Math SB; Chandrashekar CR
    J ECT; 2013 Mar; 29(1):e6-7. PubMed ID: 23422531
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolonged drug-induced Parkinsonism.
    Klawans HL; Bergen D; Bruyn GW
    Confin Neurol; 1973; 35(6):368-77. PubMed ID: 4149771
    [No Abstract]   [Full Text] [Related]  

  • 32. Asymmetry in clinical features of drug-induced parkinsonism.
    Sethi KD; Zamrini EY
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinsonism following neuroleptic withdrawal.
    Nelli AC; Yarden PE; Guazzelli M; Feinberg I
    Arch Gen Psychiatry; 1989 Apr; 46(4):383-4. PubMed ID: 2564765
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacopsychiatry and iatrogenic parkinsonism].
    Pérez de Francisco C; Garnica Portillo R
    Neurol Neurocir Psiquiatr; 1978; 19(1):53-7. PubMed ID: 30054
    [No Abstract]   [Full Text] [Related]  

  • 35. Are atypical antipsychotics associated with a reduced risk of developing parkinsonism?
    Chou KL; Friedman JH
    Nat Clin Pract Neurol; 2006 Mar; 2(3):132-3. PubMed ID: 16932538
    [No Abstract]   [Full Text] [Related]  

  • 36. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced parkinsonism in the elderly.
    Stephen PJ; Williamson J
    Lancet; 1984 Nov; 2(8411):1082-3. PubMed ID: 6150149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 39. Aripiprazole-induced Parkinsonism with pregabalin as a confounder.
    Kaur U; Ojha B; Pathak BK; Singh A; Gambhir IS; Chakrabarti SS
    Acta Neurol Belg; 2021 Oct; 121(5):1351-1356. PubMed ID: 32444941
    [No Abstract]   [Full Text] [Related]  

  • 40. Managing antipsychotic-induced parkinsonism.
    Mamo DC; Sweet RA; Keshavan MS
    Drug Saf; 1999 Mar; 20(3):269-75. PubMed ID: 10221855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.